Protection of murine gestational tissues from picornavirus infection in the preimplantation period.
Mice were inoculated with Theiler's murine encephalomyelitis virus (TMEV) on gestational days 1-3 (pre-implantation) or days 4-5 (peri- or post-implantation) or with control cell lysate (days 1-5). Dams were subsequently sacrificed between days 11-14 of gestation, and placentae and fetuses were harvested. Few placentae from dams inoculated with virus on days 1-3 were positive by virus culture (2 per cent) or in situ hybridization (6 per cent), and no fetuses were positive by either technique. In contrast, most placentae from dams inoculated with virus on days 4-5 were virus-positive by culture (96 per cent) or in situ hybridization (100 per cent), and a moderate number of fetuses were also positive (30 per cent by culture, 19 per cent by in situ hybridization). Necrosis was present more frequently in placentae from mice inoculated with virus on days 4-5 (55 per cent) than in placentae from dams inoculated with virus on days 1-3 (19 per cent) or with control cell lysate (18 per cent). Viral infection, mononuclear inflammation and cell necrosis were identified in the heart and great vessels of TMEV-infected fetuses. These results indicate that gestational tissues are largely protected from viral infection before implantation. After implantation, gestational tissues are more readily infected and damaged by maternal picornavirus infection.
Abzug
M J
MJ
Department of Pediatrics (Infectious Diseases) and Pathology, University of Colorado School of Medicine and The Children's Hospital, USA. ABZUG.MARK@TCHDEN.ORG
Tyson
R W
RW
D000818:Animals; D018188:Cardiovirus Infections / Q000473:pathology / Q000517:prevention & control* / Q000821:virology; D004195:Disease Models, Animal; D047108:Embryonic Development; D005260:Female; D005315:Fetal Diseases / Q000473:pathology / Q000821:virology; D005333:Fetus / Q000473:pathology / Q000821:virology*; D017403:In Situ Hybridization; D051379:Mice; D010920:Placenta / Q000473:pathology / Q000821:virology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000473:pathology / Q000821:virology*; D012367:RNA, Viral / Q000032:analysis; D017945:Theilovirus / Q000235:genetics / Q000302:isolation & purification; D014766:Viremia
D012367:RNA, Viral